
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Binary classification threatens the validity of cognitive impairment detection.
Maryse J. Luijendijk, Heleen E. M. Feenstra, Ivar Vermeulen, et al.
Neuropsychology (2022) Vol. 37, Iss. 3, pp. 344-350
Open Access | Times Cited: 6
Maryse J. Luijendijk, Heleen E. M. Feenstra, Ivar Vermeulen, et al.
Neuropsychology (2022) Vol. 37, Iss. 3, pp. 344-350
Open Access | Times Cited: 6
Showing 6 citing articles:
The prevalence of mild cognitive impairment in breast cancer patients receiving chemotherapy according to the criteria of the National Institute on Aging-Alzheimer’s Association (NIA-AA)
Elaine A. C. Albers, Jacobien M. Kieffer, Sanne B. Schagen
Journal of Cancer Survivorship (2024)
Open Access | Times Cited: 4
Elaine A. C. Albers, Jacobien M. Kieffer, Sanne B. Schagen
Journal of Cancer Survivorship (2024)
Open Access | Times Cited: 4
Cognitive adverse events in patients with lung cancer treated with checkpoint inhibitor monotherapy: a propensity score-matched analysis
Yifei Ma, Nianqi Liu, Yanqi Wang, et al.
EClinicalMedicine (2023) Vol. 59, pp. 101987-101987
Open Access | Times Cited: 10
Yifei Ma, Nianqi Liu, Yanqi Wang, et al.
EClinicalMedicine (2023) Vol. 59, pp. 101987-101987
Open Access | Times Cited: 10
Behavioral and biologic characteristics of cancer-related cognitive impairment biotypes
Michele M. Mulholland, Sarah Prinsloo, Elizabeth Kvale, et al.
Brain Imaging and Behavior (2023) Vol. 17, Iss. 3, pp. 320-328
Open Access | Times Cited: 7
Michele M. Mulholland, Sarah Prinsloo, Elizabeth Kvale, et al.
Brain Imaging and Behavior (2023) Vol. 17, Iss. 3, pp. 320-328
Open Access | Times Cited: 7
Neuroimaging based biotypes for precision diagnosis and prognosis in cancer-related cognitive impairment
Shelli R. Kesler, Ashley M. Henneghan, Sarah Prinsloo, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 5
Shelli R. Kesler, Ashley M. Henneghan, Sarah Prinsloo, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 5
Subgroups of cognitively affected and unaffected breast cancer survivors after chemotherapy: a data-driven approach
Joost A. Agelink van Rentergem, Philippe R. Lee Meeuw Kjoe, Ivar Vermeulen, et al.
Journal of Cancer Survivorship (2023) Vol. 18, Iss. 3, pp. 810-817
Closed Access | Times Cited: 4
Joost A. Agelink van Rentergem, Philippe R. Lee Meeuw Kjoe, Ivar Vermeulen, et al.
Journal of Cancer Survivorship (2023) Vol. 18, Iss. 3, pp. 810-817
Closed Access | Times Cited: 4
The prevalence of mild cognitive impairment in breast cancer patients receiving chemotherapy according to the criteria of the National Institute on Aging-Alzheimer’s Association (NIA-AA).
Elaine A. C. Albers, Jacobien M. Kieffer, Sanne B. Schagen
Research Square (Research Square) (2023)
Open Access
Elaine A. C. Albers, Jacobien M. Kieffer, Sanne B. Schagen
Research Square (Research Square) (2023)
Open Access